1 completed, 1 recruiting, 1 unknown. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 1, Recruiting 1, Unknown 1 |
Follow DiaSorin Molecular LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients LIAISON NES FLU A/B, RSV & COVID-19 - Influenza a, Influenza B | Not applicable | Recruiting | DiaSorin Molecular LLC | 1000 | 2024-09-30 | 2024-11-04 |
| LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia LIAISON NES FLU A/B, RSV, & COVID-19, LIAISON PLEX Respiratory Flex Assay - Influenza A, Influenza Type B | Not applicable | Unknown | DiaSorin Molecular LLC | 1000 | 2024-05-06 | 2024-04-30 |
| LIAISON NES Influenza (FLU) A/B & Coronavirus Disease 2019 (COVID-19) Clinical Agreement in Australia LIAISON NES FLU A/B & COVID-19 - Influenza A, Influenza Type B | Not applicable | Completed | DiaSorin Molecular LLC | 233 | 2023-06-19 | 2024-04-30 |
COVID-19 (3) · Adenoviridae Infections (1) · Enterovirus Infections (1) · Paramyxoviridae Infections (1) · Pneumonia, Mycoplasma (1) · Psittacosis (1) · Whooping Cough (1)
Australia (2) · United States (1)